meddevicedb.com FDA Device Reference

LigaPASS™ System

K261374 Class II Special
Decision Date
2026-05-27
Sponsor / Applicant
Medicrea International S.A.S

Technical Specification

510(k) Submission ID K261374
Product Code OWI
Medical Specialty / Panel Orthopedic
Regulation Citation 21 CFR 888.3010
Decision Date 2026-05-27
Clearance Pathway Special

Official Documentation

FDA CDRH Summary / statement of record

View FDA Summary PDF

Clearance Summary

LigaPASS™ System received FDA 510(k) clearance under submission number K261374, sponsored by Medicrea International S.A.S. The device was reviewed via the Special premarket notification pathway and assigned to the Orthopedic review panel. The statutory decision date of record is 2026-05-27.

Classification & Regulation

This clearance is catalogued under FDA product code OWI and 21 CFR 888.3010, within the Orthopedic review panel as a Class II device.